Exposure of hepatocellular carcinoma cells (HCC) to ferroptosis-inducing compounds, such as elastin and sorafenib, promotes the nuclear accumulation of Nrf2 through the inactivation of KEAP1 by p62 expression. This evidence concerns the gene KEAP1 and hepatocellular carcinoma.